Suzanne Lapierre-Roman of Allentown was diagnosed with metastatic melanoma at age 29 in July of 2005.... (Continue reading)
We believe the results show that PV-10 can be a viable treatment for metastatic melanoma, and we are focusing our efforts on completing the 80 patient study, while also making plans for our next steps in development.... (Continue reading)
Provectus Pharmaceuticals Inc. has begun a compassionate use program for PV-10 and has made the agent, which is in development as a therapeutic drug for a broad spectrum of cancers, available for select cancer patients.... (Continue reading)
Dr. Craig Dees, PhD, Chairman and Chief Executive Officer of Provectus said, "The progress we are making in the clinical trials of PV-10 helps pave the way for its possible future as a safe...... (Continue reading)